REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sermeqs S.A.S. (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Sermeqs S.A.S. Profile Updated: May 06, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

SERMEQS SAS specializes in supplying implantable medical devices for osteosynthesis material, offering a wide portfolio of specialized plates, maxillofacial, hand and foot systems, special external tutors, and joint replacement. They provide products with competitive prices and high installed capacity to respond timely to market needs. SERMEQS also provides technical support advice and a surgical instrumentator for specialists. The company has developed a technological organization for data transmission through the internet or other electronic means.

Headquarters
Kr 42 # 5 A - 67
Cali; Valle del Cauca;

Contact Details: Purchase the Sermeqs S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Sermeqs S.A.S. report to view the information.
Registered Capital:
Purchase the Sermeqs S.A.S. report to view the information.
Financial Auditors:
Purchase the Sermeqs S.A.S. report to view the information.
Incorporation Date:
June 22, 2011
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Sermeqs S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
45.17%▲
Total operating revenue
45.17%▲
Operating Profit/Loss (EBIT)
54.7%▲
EBITDA
47.65%▲
Net Profit/Loss for the Period
36.85%▲
Total Assets
24.65%▲
Total Equity
28.16%▲
Operating Profit Margin (ROS)
0.89%▲
Net Profit Margin
-0.48%▼
Return on Equity (ROE)
1.39%▲
Debt/Equity
2.11%▲
Quick Ratio
0.13%▲
Cash Ratio
0.01%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo